Patents by Inventor Mingju Cao

Mingju Cao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SUBCUTANEOUS THERAPEUTIC ENZYME FORMULATIONS, USES, AND METHODS FOR GENERATING THEREOF
    Publication number: 20220096607
    Abstract: Provided herein are compositions containing a lysosomal storage disorder replacement enzyme (LSDRE) and a dispersing agent for subcutaneous injection for treatment of lysosomal storage diseases. Kits and methods of treatment are also provided.
    Type: Application
    Filed: July 19, 2021
    Publication date: March 31, 2022
    Inventors: Mingju CAO, Alexander M. CAO
  • Subcutaneous therapeutic enzyme formulations, uses, and methods for generating thereof
    Patent number: 11065309
    Abstract: Provided herein are compositions containing a lysosomal storage disorder replacement enzyme (LSDRE) and a dispersing agent for subcutaneous injection for treatment of lysosomal storage diseases. Kits and methods of treatment are also provided.
    Type: Grant
    Filed: March 19, 2019
    Date of Patent: July 20, 2021
    Assignee: KINETIQ THERAPEUTICS, LLC
    Inventors: Mingju Cao, Alexander M. Cao
  • SUBCUTANEOUS THERAPEUTIC ENZYME FORMULATIONS, USES, AND METHODS FOR GENERATING THEREOF
    Publication number: 20190209664
    Abstract: Provided herein are compositions containing a lysosomal storage disorder replacement enzyme (LSDRE) and a dispersing agent for subcutaneous injection for treatment of lysosomal storage diseases. Kits and methods of treatment are also provided.
    Type: Application
    Filed: March 19, 2019
    Publication date: July 11, 2019
    Inventors: Mingju CAO, Alexander M. CAO
  • Subcutaneous therapeutic enzyme formulations, uses, and methods for generating thereof
    Patent number: 10286045
    Abstract: Provided herein are compositions containing a lysosomal storage disorder replacement enzyme (LSDRE) and a dispersing agent for subcutaneous injection for treatment of lysosomal storage diseases. Kits and methods of treatment are also provided.
    Type: Grant
    Filed: April 21, 2018
    Date of Patent: May 14, 2019
    Assignee: KINETIQ, INC.
    Inventors: Mingju Cao, Alexander M. Cao
  • Subcutaneous therapeutic enzyme formulations, uses, and methods for generating thereof
    Patent number: 9981021
    Abstract: Provided herein are compositions containing a lysosomal storage disorder replacement enzyme (LSDRE) and a dispersing agent for subcutaneous injection for treatment of lysosomal storage diseases. Kits and methods of treatment are also provided.
    Type: Grant
    Filed: April 7, 2016
    Date of Patent: May 29, 2018
    Assignee: KINETIQ, INC.
    Inventors: Mingju Cao, Alexander M. Cao